Ocugen (OCGN) Amortizatization of Intangibles (2017 - 2023)

Ocugen (OCGN) posted Amortizatization of Intangibles of $39000.0 for Q2 2023, down 72.73% on a QoQ basis from $143000.0 in Q1 2023.

Ocugen (OCGN) Amortizatization of Intangibles (2017 - 2023) Analysis & Trends

Ocugen's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $39000.0 for Q2 2023.

Quarterly Amortizatization of Intangibles changed N/A year-over-year to $39000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $39000.0 (down 83.88% YoY) and the FY2023 annual result came in at $182000.0, up 83.84% from the prior year.
Amortizatization of Intangibles was $39000.0 for Q2 2023 at Ocugen, down from $143000.0 in the prior quarter.
Across five years, Amortizatization of Intangibles topped out at $143000.0 in Q1 2023 and bottomed at $39000.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	3.22 Mn
10	Ocugen	415.98 Mn	415.98 Mn	-	-

Download Data